Ginkgo Bioworks Holdings Inc (NYSE:DNA) currently has a daily average trading volume of 1.43M but it saw 2035101 shares traded in last market. With a market cap of 400.95M USD, the company’s current market price of $6.85 came falling about -7.43 while comparing to the previous closing price of $7.40. In past 52 weeks, the stock remained buoying in the range of price level as high as $29.60 and as low as $5.00.
Raymond James also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $3.50 and $2.50.
Over the week, DNA’s stock price is moving -10.69% down while it is -9.87% when we observe its performance for the past one month. Year-to-date it is -30.24% down and over the past year, the stock is showing a downside performance of -77.65%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0. In next quarter, company is expected to be making quarterly sales of $43.41M as analysts are expecting the sales for current fiscal year at $175.87M and seeing the company making $200.16M in sales next year. Moreover, analysts are in estimates of $40.91M for current-quarter revenue.
Currently, Ginkgo Bioworks Holdings Inc’s total number of outstanding shares is 43.08M with 6.68% of that held by the insiders while 79.41% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -43.63% and return on equity (ROE) at -57.76%. Stock’s beta reads 1.30. Stock has a price to book (P/B) ratio of 0.55 while price to sale or P/S ratio amounts to 1.69. Its return on asset (ROA) is -32.84% on average.
